Lack of Th17 cell generation in patients with severe burn injuries

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2155-2161

  Inatsu, Akihito ^a   Kogiso, Mari ^a   Jeschke, Marc G ^b   Asai, Akira ^a   Kobayashi, Makiko ^a,b   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDA ANTIGEN; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 17; RECOMBINANT INTERLEUKIN 10; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ADOLESCENT; ADULT; ARTICLE; BURN; BURN PATIENT; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LEUKOCYTE CULTURE; LYMPHOCYTOPOIESIS; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SERUM; TH17 CELL;

ADULT; BURNS; CELLS, CULTURED; CHILD; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MYCOSES; TH17 CELLS;

EID: 80052663061     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003235     Document Type: Article

References (46)

1. Mason, A. D., Jr., A. T. McManus, and B. A. Pruitt Jr. 1986. Association of burn mortality and bacteremia: a 25-year review. Arch. Surg. 121: 1027-1031.
2. Sittig, K., and E. A. Deitch. 1988. Effect of bacteremia on mortality after thermal injury. Arch. Surg. 123: 1367-1370. (Pubitemid 18262718)
3. Murray, C. K., F. L. Loo, D. R. Hospenthal, L. C. Cancio, J. A. Jones, S. H. Kim, J. B. Holcomb, C. E. Wade, and S. E. Wolf. 2008. Incidence of systemic fungal infection and related mortality following severe burns. Burns 34: 1108-1112.
4. Horvath, E. E., C. K. Murray, G. M. Vaughan, K. K. Chung, D. R. Hospenthal, C. E. Wade, J. B. Holcomb, S. E. Wolf, A. D. Mason, Jr., and L. C. Cancio. 2007. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann. Surg. 245: 978-985. (Pubitemid 46809301)
5. Ballard, J., L. Edelman, J. Saffle, R. Sheridan, R. Kagan, D. Bracco, L. Cancio, B. Cairns, R. Baker, P. Fillari, et al Multicenter Trials Group, American Burn Association. 2008. Positive fungal cultures in burn patients: a multicenter review. J. Burn Care Res. 29: 213-221.
6. Vinsonneau, C., M. Benyamina, M. T. Baixench, J. Stephanazzi, C. Augris, S. Grabar, A. Paugam, and D. Wassermann. 2009. Effects of candidaemia on outcome of burns. Burns 35: 561-564.
7. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527. (Pubitemid 32835046)
8. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646. (Pubitemid 46785128)
9. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852. (Pubitemid 46697925)
10. Lu, Y. J., J. Gross, D. Bogaert, A. Finn, L. Bagrade, Q. Zhang, J. K. Kolls, A. Srivastava, A. Lundgren, S. Forte, et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4: e1000159.
11. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19: 377-382. (Pubitemid 351274047)
12. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631. (Pubitemid 38982105)
13. Ma, C. S., G. Y. Chew, N. Simpson, A. Priyadarshi, M. Wong, B. Grimbacher, D. A. Fulcher, S. G. Tangye, and M. C. Cook. 2008. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205: 1551-1557. (Pubitemid 351962018)
14. Eyerich, K., S. Foerster, S. Rombold, H. P. Seidl, H. Behrendt, H. Hofmann, J. Ring, and C. Traidl-Hoffmann. 2008. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 128: 2640-2645.
15. Herndon, D. N. 2007. Total Burn Care, 3rd Ed. Saunders Elsevier, Philadephia, p. 43-195.
16. Finnerty, C. C., M. G. Jeschke, D. N. Herndon, R. Gamelli, N. Gibran, M. Klein, G. Silver, B. Arnoldo, D. Remick, R. G. Tompkins; Investigators of the Inflammation and the Host Response Glue Grant. 2008. Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol. Med. 14: 553-560.
17. Gauglitz, G. G., D. N. Herndon, G. A. Kulp, W. J. Meyer, III, and M. G. Jeschke. 2009. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J. Clin. Endocrinol. Metab. 94: 1656-1664.
18. Huang, L. F., Y. M. Yao, N. Dong, Y. Yu, L. X. He, and Z. Y. Sheng. 2010. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Crit. Care 14: R3.
19. Tredget, E. E., L. Yang, M. Delehanty, H. Shankowsky, and P. G. Scott. 2006. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J. Interferon Cytokine Res. 26: 179-189.
20. Saville, S. P., A. L. Lazzell, C. Monteagudo, and J. L. Lopez-Ribot. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell 2: 1053-1060. (Pubitemid 37298719)
21. Romani, L. 1999. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2: 363-367. (Pubitemid 29366956)
22. Del Prete, G. F., M. De Carli, C. Mastromauro, R. Biagiotti, D. Macchia, P. Falagiani, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88: 346-350.
23. Utsunomiya, T., M. Kobayashi, D. N. Herndon, R. B. Pollard, and F. Suzuki. 1999. Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice. Clin. Exp. Immunol. 116: 291-298. (Pubitemid 29219727)
24. Mack, V. E., M. D. McCarter, H. A. Naama, S. E. Calvano, and J. M. Daly. 1996. Dominance of T-helper 2-type cytokines after severe injury. Arch. Surg. 131: 1303-1308, discussion 1308-1309.
25. O'Sullivan, S. T., J. A. Lederer, A. F. Horgan, D. H. Chin, J. A. Mannick, and M. L. Rodrick. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222: 482-490, discussion 490-492.
26. Gaffen, S. L. 2008. An overview of IL-17 function and signaling. Cytokine 43: 402-407.
27. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476. (Pubitemid 39370503)
28. Desai, M. H., D. N. Herndon, and S. Abston. 1987. Candida infection in massively burned patients. J. Trauma 27: 1186-1188. (Pubitemid 18005119)
29. Prasad, J. K., I. Feller, and P. D. Thomson. 1987. A ten-year review of Candida sepsis and mortality in burn patients. Surgery 101: 213-216. (Pubitemid 17026557)
30. Still, J. M., Jr., K. Belcher, and E. J. Law. 1995. Management of candida septicaemia in a regional burn unit. Burns 21: 594-596.
31. Inatsu, A., S. Yoshida, A. Asai, M. Kobayashi, D. N. Herndon, and F. Suzuki. 2010. IL-17 promotes the conversion of normal neutrophils to PMN-I, an immunostimulating subset of neutrophils. J. Immunol. 184: 34.14 (Abstr.).
32. Yeh, F. L., W. L. Lin, H. D. Shen, and R. H. Fang. 1997. Changes in serum tumour necrosis factor-a in burned patients. Burns 23: 6-10.
33. Yeh, F. L., W. L. Lin, H. D. Shen, and R. H. Fang. 1999. Changes in circulating levels of interleukin 6 in burned patients. Burns 25: 131-136. (Pubitemid 29134668)
34. Csontos, C., V. Foldi, L. Pálinkas, L. Bogar, E. Röth, G. Weber, and J. Lantos. 2010. Time course of pro- and anti-inflammatory cytokine levels in patients with burns: prognostic value of interleukin-10. Burns 36: 483-494.
35. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
36. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf, J. W. Van der Meer, J. H. Van Krieken, T. Hartung, G. Adema, and B. J. Kullberg. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712-3718. (Pubitemid 38337955)
37. Gu, Y., J. Yang, X. Ouyang, W. Liu, H. Li, J. Yang, J. Bromberg, S. H. Chen, L. Mayer, J. C. Unkeless, and H. Xiong. 2008. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur. J. Immunol. 38: 1807-1813.
38. McKinstry, K. K., T. M. Strutt, A. Buck, J. D. Curtis, J. P. Dibble, G. Huston, M. Tighe, H. Hamada, S. Sell, R. W. Dutton, and S. L. Swain. 2009. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J. Immunol. 182: 7353-7363.
39. + T cell population of rheumatoid arthritis patients. Immunol. Lett. 127: 150-156.
40. Dugan, A. L., W. B. Malarkey, S. Schwemberger, E. C. Jauch, C. K. Ogle, and N. D. Horseman. 2004. Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality. J. Burn Care Rehabil. 25: 306-313. (Pubitemid 38637789)
41. Kobayashi, M., H. Kobayashi, D. N. Herndon, R. B. Pollard, and F. Suzuki. 1998. Burn-associated Candida albicans infection caused by CD30+ type 2 T cells. J. Leukoc. Biol. 63: 723-731. (Pubitemid 28274834)
42. Kobayashi, M., M. G. Jeschke, K. Shigematsu, A. Asai, S. Yoshida, D. N. Herndon, and F. Suzuki. 2010. M2b monocytes predominated in peripheral blood of severely burned patients. J. Immunol. 185: 7174-7179.
43. Kilani, R. T., M. Delehanty, H. A. Shankowsky, A. Ghahary, P. Scott, and E. E. Tredget. 2005. Fluorescent-activated cell-sorting analysis of intracellular interferon-γ and interleukin-4 in fresh and frozen human peripheral blood T-helper cells. Wound Repair Regen. 13: 441-449. (Pubitemid 41060426)
44. Croft, M., and S. L. Swain. 1995. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 154: 4269-4282.
45. Ikemoto, K., R. B. Pollard, T. Fukumoto, M. Morimatsu, and F. Suzuki. 1995. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1. J. Immunol. 155: 1326-1333.
46. Schulze-Koops, H., P. E. Lipsky, and L. S. Davis. 1998. Human memory T cell differentiation into Th2-like effector cells is dependent on IL-4 and CD28 stimulation and inhibited by TCR ligation. Eur. J. Immunol. 28: 2517-2529. (Pubitemid 28362726)